Anatara Lifesciences Ltd (ASX:ANR)

Anatara Lifesciences Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	1.05	0.98	0.35	1.12	3.43	2.68
Short-Term Investments	0.05	-	0.05	0.05	-	-
Cash & Short-Term Investments	1.1	0.98	0.4	1.17	3.43	2.68
Cash Growth	1.58%	144.80%	-65.72%	-65.90%	27.95%	-50.42%
Other Receivables	0.61	0.67	1	0.51	0.77	0.63
Receivables	0.61	0.67	1	0.51	0.77	0.63
Other Current Assets	0.05	0.02	0.01	0.02	0.04	0.02
Total Current Assets	1.76	1.67	1.42	1.7	4.24	3.34
Property, Plant & Equipment	0	0	0	0.07	0.09	0.01
Total Assets	1.76	1.67	1.42	1.77	4.33	3.34
Accounts Payable	0.37	0.25	0.44	0.15	0.2	0.03
Accrued Expenses	0.03	0.03	0.02	0.15	0.16	0.4
Current Portion of Leases	-	-	-	0.02	0.01	-
Other Current Liabilities	-	0.02	0.04	0.03	0.04	0.03
Total Current Liabilities	0.4	0.3	0.49	0.36	0.4	0.46
Long-Term Leases	-	-	-	0.05	0.07	-
Total Liabilities	0.4	0.31	0.49	0.4	0.5	0.49
Common Stock	24.17	23.18	21.37	19.91	19.76	17.04
Retained Earnings	-23.25	-22.09	-20.79	-18.98	-16.6	-14.74
Comprehensive Income & Other	0.43	0.28	0.35	0.44	0.68	0.55
Shareholders' Equity	1.36	1.36	0.92	1.36	3.83	2.86
Total Liabilities & Equity	1.76	1.67	1.42	1.77	4.33	3.34
Total Debt	-	-	-	0.07	0.08	-
Net Cash (Debt)	1.1	0.98	0.4	1.1	3.35	2.68
Net Cash Growth	1.58%	144.80%	-63.67%	-67.05%	24.97%	-50.42%
Net Cash Per Share	0.01	0.01	0.00	0.02	0.05	0.05
Filing Date Shares Outstanding	213.38	191.14	119.92	71.36	70.24	49.86
Total Common Shares Outstanding	213.38	191.14	119.92	71.36	70.24	49.86
Working Capital	1.36	1.37	0.92	1.34	3.84	2.87
Book Value Per Share	0.01	0.01	0.01	0.02	0.05	0.06
Tangible Book Value	1.36	1.36	0.92	1.36	3.83	2.86
Tangible Book Value Per Share	0.01	0.01	0.01	0.02	0.05	0.06

Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.